| Sitemap | Subscribe | Contact Us | ||
|
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
Latest Type 1 Articles
A multinational 10-year study, known as the Trial to Reduce Insulin-Dependent Diabetes in the Genetically at Risk (TRIGR), is enlisting the participation of newborns who have a parent or sibling with type 1 diabetes.
TRIGR is the first diabetes trial that will assess the relationship of infant formula consumption to the likelihood of developing type 1 diabetes in genetically susceptible infants. Its results could lead to early interventions, before babies develop antibodies that signal the beginning of an autoimmune attack that destroys the insulin-creating islet cells in the pancreas.
The study, which encourages and emphasizes breast-feeding, will compare several groups of breast-fed babies. When the babies are weaned, or if an infant needs supplementation, the diet of one group will be supplemented with a study formula called Nutramigen, a hydrolyzed cow's milk-based formula, in which the protein casein is broken down into smaller molecules, which are likely to be too small to stimulate the immune system. Another group of infants will supplement with Enfamil, a standard cow's milk-based formula (not hydrolyzed).
Researchers in Canada have shown that hydrolyzed cow's milk formula reduces the incidence of type 1 diabetes in diabetes-prone rats and mice by as much as 80 to 90 percent. They speculate that the absence of intact protein in the formula may be the reason.
If you are interested in having your baby participate in the TRIGR study, contact Peggy Franciscus, RN, at (412) 692-5250 or by e-mail at m_franciscus @yahoo.com, before or immediately after the baby's birth. For more information on the TRIGR study, log on to www.trigr.org.
The following U.S. sites are involved in the study:
St. Louis, Missouri
Seattle, Washington
New York, New York
Los Angeles, California
Pittsburgh, Pennsylvania
Puerto Rico
18 comments - 1 May 2008
18 comments - 1 May 2008
11 comments - 21 Apr 2008
8 comments - 28 Apr 2008
Comments...
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register..
Register your Diabetes Health Username here.
Have Your Say...